Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Osteoarthritis study

This article was originally published in The Tan Sheet

Executive Summary

Spanish firm BioIberica will supply chondroitin sulfate for the NIH-funded study on osteoarthritis, an NIH steering committee decides Sept. 28. Pfanstiehl Labs is providing the glucosamine. The trial, co-sponsored by NCCAM and NIAMS, was slated to start several months ago but was stalled due to difficulty in choosing supplement suppliers (1"The Tan Sheet" Sept. 4, p. 4). Enrollment is expected to begin in late October

You may also be interested in...



Suppliers See Ingredient Branding As Key To Greater Market Presence

Supply firms are focusing on branding their ingredients as they pursue category leadership within the dietary supplement industry

Suppliers See Ingredient Branding As Key To Greater Market Presence

Supply firms are focusing on branding their ingredients as they pursue category leadership within the dietary supplement industry

Suppliers See Ingredient Branding As Key To Greater Market Presence

Supply firms are focusing on branding their ingredients as they pursue category leadership within the dietary supplement industry

Topics

UsernamePublicRestriction

Register

SC081785

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel